Pharmacodynamics and Pharmacokinetics of Thiopental
Overview
Authors
Affiliations
Thiopental is an ultra short-acting barbiturate which remains the standard against which other induction agents are judged; it is also indicated for the therapy of brain hypoxic-ischaemia injuries and status epilepticus. Aspects of drug distribution that govern the onset and end of drug effect have been intensively studied to determine which parameters (in patient characteristics, diseases and administration modalities) influence effective dose and concentrations in individual patients. Thiopental has been used as a reference for pharmacokinetic and/or pharmacodynamic models in the study of rapid and short acting effect drugs. In anaesthesiology the pharmacokinetics of thiopental are described as linear; when doses and duration of treatment increase, nonlinear pharmacokinetics occur because of the saturation and/or the induction of the metabolism.
General Anesthetics: Aspects of Chirality, Pharmacodynamics, and Pharmacokinetics.
cizmarikova R, Habala L, Valentova J Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006063 PMC: 11860141. DOI: 10.3390/ph18020250.
Dabricot E, Seqat I, Dailler F, Rheims S, Boulogne S, Balanca B Crit Care. 2021; 25(1):439.
PMID: 34920743 PMC: 8684170. DOI: 10.1186/s13054-021-03851-8.
[Pharmacotherapy and intensive care aspects of status epilepticus: update 2020/2021].
Saitov G, Muller A, Bastian B, Michalski D Anaesthesist. 2021; 70(10):874-887.
PMID: 34212230 PMC: 8492596. DOI: 10.1007/s00101-021-01000-y.
Current State of Analgesia and Sedation in the Pediatric Intensive Care Unit.
Egbuta C, Mason K J Clin Med. 2021; 10(9).
PMID: 33922824 PMC: 8122992. DOI: 10.3390/jcm10091847.
Impact of Skull Defects on the Role of CTA for Brain Death Confirmation.
Nunes D, Maia Jr A, Boni R, da Rocha A AJNR Am J Neuroradiol. 2019; 40(7):1177-1183.
PMID: 31196858 PMC: 7048557. DOI: 10.3174/ajnr.A6100.